Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?

The surge in coronavirus disease 2019 (COVID-19) caused by the Omicron variants of the severe acute respiratory syndrome coronavirus 2 necessitates researches to inform vaccine effectiveness (VE) and other preventive measures to halt the pandemic. A test-negative case–control study was conducted amo...

Cijeli opis

Bibliografski detalji

Glavni autori:	Paskorn Sritipsukho, Thana Khawcharoenporn, Boonying Siribumrungwong, Pansachee Damronglerd, Nuntra Suwantarat, Araya Satdhabudha, Chanapai Chaiyakulsil, Phakatip Sinlapamongkolkul, Auchara Tangsathapornpong, Pornumpa Bunjoungmanee, Sira Nanthapisal, Chamnan Tanprasertkul, Naiyana Sritipsukho, Chatchai Mingmalairak, Anucha Apisarnthanarak, Pichaya Tantiyavarong
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis Group 2023-12-01
Serija:	Emerging Microbes and Infections
Teme:	COVID-19 real-life vaccine effectiveness Omicron variant Thailand
Online pristup:	https://www.tandfonline.com/doi/10.1080/22221751.2023.2174779
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!